Cleared Traditional

K081498 - TENSO-COMFORT BLOOD PRESSURE METER

K081498 is the FDA 510(k) clearance for TENSO-COMFORT BLOOD PRESSURE METER by Biocomfort Diagnostics GmbH & Co. KG. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Traditional 510(k) pathway after a 202-day FDA review.

K081498 · Biocomfort Diagnostics GmbH & Co. KG · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2008
Decision
202d
Days
Class 2
Risk

K081498 is an FDA 510(k) clearance for the TENSO-COMFORT BLOOD PRESSURE METER, MODELS BPM 105 AND BPM 205. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Biocomfort Diagnostics GmbH & Co. KG (Neuhausen A.D.F., DE). The FDA issued a Cleared decision on December 17, 2008 after a review of 202 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Biocomfort Diagnostics GmbH & Co. KG devices

Submission Details

510(k) Number K081498 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 29, 2008
Decision Date December 17, 2008
Days to Decision 202 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
77d slower than avg
Panel avg: 125d · This submission: 202d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 509
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K081498.
FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR, MODEL KD-5902
K083317 · Andon Health Co, Ltd. · Jan 2009
FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR, MODEL KD-5904
K083318 · Andon Health Co, Ltd. · Jan 2009
FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR, MODEL KD-7941
K083319 · Andon Health Co, Ltd. · Jan 2009
MICROLIFE UPPER ARM AUTOMATIC DIGITAL BLOOD PRESSURE MONITOR, MODEL WATCHBP O3
K082881 · Microlife Intellectual Property GmbH · Nov 2008
A&D MEDICAL UA-851THW DIGITAL BLOOD PRESSURE MONITOR
K082734 · A&D Engineering, Inc. · Nov 2008
MICROLIFE UPPER ARM AUTOMATIC DIGITAL BLOOD PRESSURE MONITOR, MODELWATCHBP OFFICE (TWIN200).
K082357 · Microlife Intellectual Property GmbH · Oct 2008